Preradiation chemotherapy in primary high-risk brainstem tumors: Phase II study CCG-9941 of the children's cancer group

Journal of Clinical Oncology

Volumn 20, Issue 16, 2002, Pages 3431-3437

  Jennings, Mark T ^a   Sposto, Richard ^a   Boyett, James M ^a   Vezina, L Gilbert ^a   Holmes, Emi ^a   Berger, Mitchell S ^a   Bruggers, Carol S ^a   Bruner, Janet M ^a   Chan, Ka Wah ^a   Dusenbery, Kathryn E ^a   Ettinger, Lawrence J ^a   Fitz, Charles R ^a   Lafond, Deborah ^a   Mandelbaum, David E ^a   Massey, Vicky ^a   McGuire, Warren ^a   McNeely, Lee ^a   Moulton, Thomas ^a   Pollack, Ian F ^a   Shen, Violet ^a  

^a CHILDREN S ONCOLOGY GROUP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYUREA; METHOTREXATE; MISONIDAZOLE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ADOLESCENT; ARTICLE; BRAIN STEM TUMOR; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DRUG EFFICACY; DRUG SAFETY; FEBRILE NEUTROPENIA; FEMALE; GLIOMA; HIGH RISK POPULATION; HUMAN; HYPERFRACTIONATED EXTERNAL BEAM RADIOTHERAPY; LEUKOPENIA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN STEM NEOPLASMS; CARBOPLATIN; CHILD; CHILD, PRESCHOOL; CISPLATIN; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; ETOPOSIDE; FEMALE; GLIOMA; HUMANS; MALE; NEOADJUVANT THERAPY; SURVIVAL RATE; VINCRISTINE;

EID: 0037102359     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.04.109     Document Type: Article

References (32)

1. Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas: A Children's Cancer Group phase I/II trial
2. Strategies in the treatment of diffuse pontine gliomas: The therapeutic role of hyperfractionated radiotherapy and chemotherapy
3. Multiple daily fractionation in radiotherapy: Biological rationale and preliminary clinical experiences
4. Accelerated fractionation vs hyperfractionation: Rationales for several treatments per day
5. Biologic basis for altered fractionation schemes
6. Basic mechanisms of radiation cell injury
7. Solid tumor models for the assessment of different treatment modalities: XXVI. Estimates of cell survival from tumor growth delay after alternating radiotherapy and chemotherapy
8. Primary glial tumor patients treated by combining cis-platin and etoposide
9. Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors
10. Efficacy of postoperative chemotherapy using cisplatin plus etoposide in young children with brain tumors
11. High-dose carboplatinum in combination with etoposide (JET regimen) for childhood brain tumors
12. Treatment of children with recurrent brain tumors with ifosfamide (IFOS), etoposide (VP16), and mesna (M): Results of a phase II trial
13. Postoperative chemotherapy and delayed radiotherapy in children less than three years of age with malignant brain tumors
14. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: Results of a randomized trial
15. A randomized phase III trial of chemotherapy for childhood high-grade astrocytoma: Report of the Children's Cancer Study Group trial CCG-945
16. Hyperfractionated radiation therapy for gliomas of the brainstem in children and in adults
17. The new WHO classification of brain tumors
18. Grading of astrocytomas: A simple and reproducible method
19. Tumor size, sensitivity to chemotherapy and the design of treatment schedules
20. 5-Fluorouracil and 1-(2-chloroethyl)-3-cyclohexyl-L-nitrosourea (CCNU) followed by hydroxurea, misonidazole, and irradiation for brainstem gliomas: A pilot study of the Brain Tumor Research Center and the Children's Cancer Group
21. Brain-stem tumors in childhood: A prospective randomized trial of irradiation with and without adjuvant CCNU, VCR and prednisone
22. Combination chemotherapy with cyclophosphamide, vincristine, procarbazine and prednisone (COPP) in children with brain tumors
23. Eight drugs in one day chemotherapy for brain tumors: Experience with 107 children and rationale for preradiation chemotherapy
24. Hyperfractionated radiotherapy and polychemotherapy in brain stem tumors in children
25. Effectiveness of interferon-beta, ACNU, and radiation therapy in pediatric patients with brainstem glioma
26. Pre-irradiation chemotherapy and hyperfractionated radiation therapy 66 Gy for children with brain stem tumors: A phase II study of the Pediatric Oncology Group, protocol 8833
27. High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors: Children's Cancer Group
28. A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate
29. Dexamethasone induces partial resistance to cisplatinum in C 6 glioma cells